Provenge
Generic name: Sipuleucel-T
Drug class:
Therapeutic vaccines
Usage of Provenge
Provenge contains a protein that stimulates the body's immune system to help it respond against certain cancer cells.
Provenge is an immunotherapy medicine used to treat advanced prostate cancer in men.
Provenge is mixed with certain immune cells drawn from your own blood, and the mixture is later injected into your body. This type of treatment is called autologous immunotherapy.
Provenge is usually given after surgery or other medications have been tried without success.
Provenge side effects
Get emergency medical help if you have signs of an allergic reaction to Provenge: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Some side effects may occur during the injection or within the first 24 hours afterward. Tell your caregiver if you feel tired, dizzy, nauseated, light-headed, feverish, chilled, or have fast heartbeats, trouble breathing, a severe headache, or pounding in your neck or ears.
Call your doctor at once if you have:
Common Provenge side effects may include:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Before taking Provenge
To make sure Provenge is safe for you, tell your doctor if you have ever had:
Relate drugs
How to use Provenge
Usual Adult Dose for Prostate Cancer:
3 complete doses given at approximately 2-week intervals; infuse drug intravenously over 60 minutes. Comments: -Peripheral blood mononuclear cells from patients are obtained via the leukapheresis procedure, which should be performed approximately 3 days prior to each infusion. -Patients should be pre-medicated orally with acetaminophen and an antihistamine (such as diphenhydramine) approximately 30 minutes prior to administration to minimize potential acute infusion reactions. -The patient should be observed for acute infusion reactions for at least 30 minutes following each infusion. -The maximum dosing interval has not been established. -This drug is intended solely for autologous use. -This drug is for IV use only; a cell filter should not be used. Use: Treatment of asymptomatic or minimally symptomatic metastatic castrate-resistant (hormone-refractory) prostate cancer.
Warnings
Before you are treated with Provenge, tell your doctor about all of your medical conditions, especially heart disease, asthma, COPD or other breathing problems, or if you have ever had a stroke.
Provenge is used in a treatment called autologous immunotherapy. Sipuleucel-T is mixed with certain immune cells drawn from your own blood, and this mixture is injected into your body.
Your doctor will determine your schedule for cell collection and Provenge injection. Follow your doctor's instructions very carefully. The timing of cell collection in relation to Provenge infusion is extremely important. If you miss an infusion appointment your prepared infusion cannot be used in the future. Some people receiving this injection have had a reaction to the infusion (when the medicine is injected into the vein). Tell your caregiver right away if you feel dizzy, tired, or nauseated, or if you have fever, chills, joint pain, severe headache, blurred vision, buzzing in your ears, anxiety, confusion, vomiting, chest pain, fast or uneven heartbeats, wheezing, chest tightness, or trouble breathing. These side effects may occur during the Provenge injection or within the first 24 hours after your infusion.
What other drugs will affect Provenge
Tell your doctor if you use any drugs that weaken your immune system, such as:
This list is not complete. Other drugs may interact with sipuleucel-T, including prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible drug interactions are listed here.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions